Bone Marrow WT1 Levels in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplasia: Clinically Relevant Time Points and 100 Copies Threshold Value.

导出原文传递

翻译打印收藏纠错

作者： Josep F,Nomdedéu ^[1] ; Albert,Esquirol ^[2] ; Maite,Carricondo ^[3] ; Marta,Pratcorona ^[3] ; Montserrat,Hoyos ^[3] ; Ana,Garrido ^[2] ; Miguel,Rubio ^[3] ; Elena,Bussaglia ^[3] ; Irene,García-Cadenas ^[2] ; Camino,Estivill ^[3] ; Salut,Brunet ^[2] ; Rodrigo,Martino ^[2] ; Jorge,Sierra ^[2]

作者单位： Hematology Laboratory, IIB-Sant Pau and Jose Carreras Leukemia Research Institutes, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: jnomdedeu@santpau.cat. ^[1] Hematopoietic Transplant Program, Hematology Department, IIB-Sant Pau and Jose Carreras Leukemia Research Institutes, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain. ^[2] Hematology Laboratory, IIB-Sant Pau and Jose Carreras Leukemia Research Institutes, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain. ^[3]

关键词 Hematopoietic stem cell transplantation Leukemia Minimal residual disease Molecular diagnostics Remission status WT1